Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Not yet recruiting 1Completed 1

Sponsor Class

OTHER 995INDUSTRY 257NIH 104NETWORK 28OTHER_GOV 16FED 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2

Conditions

Rare Diseases 2Neurofibromatosis 2 2Glioma 2Glioblastoma 2Genetic Diseases, Inborn 2Oligodendroglioma 1Neuroma, Acoustic 1Neurologic Manifestations 1Neurofibromatoses 1Mental Disorders 1Hearing Loss 1Brain Neoplasms 1Astrocytoma 1

Interventions

Streptozocin 1Mercaptopurine 1Carmustine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
FED × Glioma × CNS × Clear all
NCT07218367 2026-02-13

Phase I Trial of pH Resections of GBM at VA

VA Office of Research and Development

Phase 1 Not yet recruiting
12 enrolled
CNS

Glioblastoma, Glioma

NCT00004688 2015-03-25

Phase II Study of Carmustine, Streptozocin, and Mercaptopurine for Refractory or Recurrent Brain Neoplasms

FDA Office of Orphan Products Development

Phase 2 Completed
35 enrolled
CNS

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Oligodendroglioma, Genetic Diseases, Inborn, Rare Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡